Workflow
Nutrients
icon
Search documents
3 Ancillary Cannabis Stocks Set to Benefit from Industry Growth in 2025
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-07-17 14:00
Industry Overview - The U.S. legal cannabis market is projected to reach nearly $45 billion by 2025, with continued double-digit growth expected over the next several years [1] - State-level legalization is gaining momentum, with bipartisan bills being introduced more frequently, contributing to a positive long-term outlook despite federal reform uncertainties [2] Company Summaries GrowGeneration Corp. (GRWG) - GrowGeneration operates over 70 stores across 22 states, focusing on hydroponic and garden supply retail, with a significant presence in California, Colorado, Florida, Michigan, and New York [3] - In Q1 2025, GrowGeneration reported net revenue of $35.7 million, a year-over-year decline, but improved gross margin to 27.2% through better inventory management and reduced discounting [7] - The company maintained strong liquidity with over $50 million in cash and no debt, despite a net loss of $9.4 million [8] Hydrofarm Holdings Group, Inc. (HYFM) - Hydrofarm is a leading manufacturer and distributor of hydroponic equipment, operating nine distribution centers across North America and Europe, with a focus on indoor cannabis cultivation [9] - In Q1 2025, Hydrofarm reported net sales of $40.5 million, a significant decline attributed to oversupply in cannabis markets, while gross profit margins remained above 20% [10] - The company posted a net loss of $14.4 million but ended the quarter with over $13 million in cash and available credit, focusing on cost discipline and brand consolidation [11] Scotts Miracle-Gro Company (SMG) - Scotts Miracle-Gro, known for lawn and garden care, has a significant role in the cannabis supply chain through its Hawthorne Gardening subsidiary, which focuses on hydroponic equipment and nutrients [12] - In Q2 2025, Scotts reported total sales of $1.42 billion, a decline from the previous year, but gross margins improved to approximately 39% due to cost efficiencies [15] - The company delivered adjusted earnings per share of $3.98, with management reaffirming full-year earnings and cash flow guidance, expecting non-GAAP adjusted EBITDA to reach $570 to $590 million [16] Investment Insights - Ancillary cannabis stocks like GrowGeneration, Hydrofarm, and Scotts Miracle-Gro provide exposure to the cannabis sector without the regulatory risks associated with plant-touching companies [17] - These companies are adapting to weak cultivation demand by focusing on higher-margin products and operational efficiencies, positioning themselves for potential recovery if market conditions improve [18] - Investors should monitor these stocks as they represent different strategies to gain cannabis exposure while managing risk [19]
dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion
Globenewswire· 2025-06-27 05:00
Core Viewpoint - dsm-firmenich has announced an increase in its share repurchase program to a total of €1.08 billion, following the completion of the sale of its stake in the Feed Enzymes Alliance [1][2]. Group 1: Share Repurchase Program Details - The initial share repurchase program was set at €500 million, which has now been increased to €1.08 billion [1][2]. - The program commenced on April 1, 2025, with an initial amount of €580 million allocated for repurchase, including €80 million for share-based compensation plans [2]. - The increased share repurchase program will be completed no later than January 30, 2026 [2]. Group 2: Execution and Compliance - The share repurchase will be executed in accordance with the Market Abuse Regulation and Swiss law [3]. - dsm-firmenich has engaged a bank to manage the execution of the share repurchase program independently [3]. Group 3: Current Status of Share Repurchase - As of the press release date, approximately 3.6 million ordinary shares have been repurchased, leaving around 8.1 million shares, or 3.0% of ordinary shares issued, still to be repurchased [4]. Group 4: Communication and Reporting - The company will provide weekly updates to the market regarding the progress of the share repurchase program [5].